Tirzepatide, a novel medication, is sparking considerable interest within the scientific community. It works differently from common diabetes medications, targeting both receptors involved in sugar regulation and hunger . Initial trials have demonstrated significant efficacy in reducing blood sugar in individuals with adult-onset diabetes and, stri